| Dr Indyah Brown, MD | |
|
801 Ostrum St, Bethlehem, PA 18015-1000 | |
| (484) 526-2583 | |
| Not Available |
| Full Name | Dr Indyah Brown |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 801 Ostrum St, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134786577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MT217235 (Pennsylvania) | Primary |
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Since the discovery of penicillin in 1928, antibiotics have made the world a much safer and healthier place. But Shakespeare was onto something when he asked if it's possible to have too much of a good thing. In the case of antibiotics, the answer is increasingly "yes."
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Northwest Biotherapeutics today announced that four medical centers across the country are actively recruiting and screening to enroll additional new patients in the Company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax immune therapy for Glioblastoma multiforme, the most lethal type of brain cancer.
Anti cancer drugs that have been rejected by the UK Government's new cancer drugs fund would still be available to needy patients according to the new ‘top-up' cash plan that is being launched. This Health Top-Up cash plan comes from Western Provident Association (WPA).
› Verified 5 days ago
| Entity Name | Star Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Since the discovery of penicillin in 1928, antibiotics have made the world a much safer and healthier place. But Shakespeare was onto something when he asked if it's possible to have too much of a good thing. In the case of antibiotics, the answer is increasingly "yes."
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Northwest Biotherapeutics today announced that four medical centers across the country are actively recruiting and screening to enroll additional new patients in the Company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax immune therapy for Glioblastoma multiforme, the most lethal type of brain cancer.
Anti cancer drugs that have been rejected by the UK Government's new cancer drugs fund would still be available to needy patients according to the new ‘top-up' cash plan that is being launched. This Health Top-Up cash plan comes from Western Provident Association (WPA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Indyah Brown, MD 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-2583 | Dr Indyah Brown, MD 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-2583 |
News Archive
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Since the discovery of penicillin in 1928, antibiotics have made the world a much safer and healthier place. But Shakespeare was onto something when he asked if it's possible to have too much of a good thing. In the case of antibiotics, the answer is increasingly "yes."
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
Northwest Biotherapeutics today announced that four medical centers across the country are actively recruiting and screening to enroll additional new patients in the Company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax immune therapy for Glioblastoma multiforme, the most lethal type of brain cancer.
Anti cancer drugs that have been rejected by the UK Government's new cancer drugs fund would still be available to needy patients according to the new ‘top-up' cash plan that is being launched. This Health Top-Up cash plan comes from Western Provident Association (WPA).
› Verified 5 days ago
Carolyn Botros, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1770 Bathgate Rd Ste 401, Bethlehem, PA 18017 Phone: 484-884-8840 Fax: 484-884-8827 | |
Dr. Emer Colalillo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 834 Eaton Ave, Bethlehem, PA 18018 Phone: 484-526-7474 | |
Sarah Jane Cathryn Muder, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-503-8217 | |
Dr. Anita Sargent, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 325 W Broad St, 3rd Floor, Bethlehem, PA 18018 Phone: 424-626-9250 Fax: 484-626-9255 | |
Dr. Kathleen Eleanor Ackert, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4670 | |
Dr. John Roizin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 31 S Commerce Way, Bethlehem, PA 18017 Phone: 484-821-0821 Fax: 484-821-0826 | |
Dr. Melat Worku Tiruneh, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4670 Fax: 833-828-1814 |